血浆纤维蛋白原

  • 网络FIB;Fbg
血浆纤维蛋白原血浆纤维蛋白原
  1. Logistic回归分析表明心脏事件发生与血管性假血友病因子、抗凝血酶Ⅲ、血浆血小板颗粒膜糖蛋白140、血浆纤维蛋白原变化尤其密切,并且后者变化与内皮功能失调及脂质过氧化损伤密切相关。

    Logistic regression analysis showed that there were close relationships between cardiac events and vWF , AT ⅲ, GMP 140 , Fbg , which were closely related with endothelial disfunction and injury of lipid peroxide .

  2. 血清胆固醇水平与血浆纤维蛋白原水平和纤溶酶原激活物抑制剂-1活性呈显著的正相关性(P<0.05)。

    Serum cholesterol level was also positively correlated with plasma fibrinogen level and PAI-1 activity ( P0.05 ) .

  3. 影响血浆纤维蛋白原水平的多因素Logistic回归分析

    Multiple factors influencing the plasma fibrinogen level and their Logistic regression analysis

  4. 手术后血浆纤维蛋白原、IL-6的水平变化及临床意义

    Clinical implication of changes of plasma FBG and IL 6 levels after operation

  5. 结论HP感染与冠心病的发生有关,慢性Hp感染不会导致血浆纤维蛋白原浓度升高。

    Conclusion This study suggests that infection with Hp is associated with CHD and has no relation with plasma Fg .

  6. 进展组患者血糖、血浆纤维蛋白原浓度、血清同型半胱氨酸含量高于非进展组,差异有统计学意义(P<0.05)。

    PCI group was higher than non-progression group in blood glucose , Plasma fibrinogen concentration and plasma homocysteine concentration , and there was statistically significant difference between the two groups ( P ﹤ 0.05 ) .

  7. 同时测定APTT、ELT和血浆纤维蛋白原的含量。

    APTT , ELT and fibrinogen were determined .

  8. 应用辅助血浆纤维蛋白原活性测定系统测定Fg浓度、纤维蛋白单体聚合速率与最大光密度的比值(FMPV/Amax)。

    The Fg concentration , FMPV / Amax were tested with assisting plasm Fg activity assay system .

  9. 目的:探讨羟基磷灰石(HA)薄膜的制备方法及其对人血浆纤维蛋白原(Fib)的吸附性能。

    Objective : To explore the fabrication process of hydroxyapatite ( HA ) films and its adsorptive properties of human fibrinogen ( Fib ) .

  10. 观察40例急性心肌梗塞(AMI)血浆纤维蛋白原(Fg)水平的动态变化。

    S : The dynamic change of plasma fibrinogen ( Fg ) level in 40 patients with acute myocardial infarction ( AMI ) was observed .

  11. 目的建立一种压电石英晶体传感器检测血浆纤维蛋白原(Fib)的方法。

    Objective A method of using piezoelectric quartz crystal sensor to detect blood plasma fibrinogen ( FIB ) is given .

  12. 方法对30例COPD患者治疗前后血氧分压、血浆纤维蛋白原及30例对照组的血浆纤维蛋白原分别进行测定。

    Methods The plasma fibrinogen level was measured in 30 patients with chronic obstructive pulmonary disease and in 30 controls . PaO2 was measured in 30 patients with COPD .

  13. 方法运用PCR限制性内切酶片段长度多态性技术,检测脑梗死组132例、其他神经疾病对照组79例和正常老年对照组92例的血浆纤维蛋白原水平及5种基因多态性。

    Methods Fg level and its five gene polymorphisms were analyzed with by polymerase chain reaction-restriction fragment length polymorphism in 132 patients with cerebral infarction , 79 patients with other neurological diseases and 92 healthy elders .

  14. 本文通过对126例急性期和恢复期脑梗塞患者、80例对照者血浆纤维蛋白原(Fg)浓度、血清白蛋白(A)、球蛋白(G)及A/G比例进行检测。

    Abstract The serum albumin ( A ), globulins ( G ), A / G ratio and the plasma concentration of fibrinogen were measured in 126 patients with cerebral infarction and 80 healthy controls .

  15. 方法对445例无活动性炎症的男女性中老年成人检测ESR-K、血浆纤维蛋白原及红细胞压积,并作动态ESR分析。

    Method ESR , hematocrit and plasma fibrinogen level of 445 middle age and elder male and female individuals were examined and dynamic ESR analysis to all subjects was performed .

  16. β纤维蛋白原基因启动子区HaeⅢ多态性和血浆纤维蛋白原浓度与脑梗死的相关性研究

    The association between β Hae ⅲ polymorphism located in the promoter region of β fibrinogen gene , plasma fibrinogen levels and cerebral infarction

  17. 结论临床可通过ESR检查,结合动态分析、观察无活动性炎症的中老年病人的血浆纤维蛋白原水平变化,对缺血性心脑血管疾病的预防、治疗有重要意义。

    Conclusion ESR examination or combining with dynamic ESR analysis can be used for observing plasma fibrinogen level changing and has important clinical significance to prevent and therapy ischemic cardio-cerebrovascular disease risk .

  18. 目的:研究β纤维蛋白原启动区-455G/A基因多态性和血浆纤维蛋白原浓度与急性冠状动脉综合征(ACS)之间的关系。

    Objectives To investigate the relationship between the β fibrinogen gene - 455G / A polymorphism and plasma fibrinogen level and to determine the influence of the acute coronary syndromes .

  19. 目的研究血浆纤维蛋白原(FG)和D-二聚体(DD)与冠心病(CHD)的关系及其临床意义。

    Objective To explore the changes and their clinical significance of plasma fibrinogen ( FG ) and D-dimer ( DD ) in patients with coronary heart disease ( CHD ) .

  20. 观察介入性动脉内输注巴曲酶药物对ASO患者血浆纤维蛋白原水平和血管病变局部氧化应激水平的影响。

    To investigate the effects of interventional transfusion of Batroxobin on plasma fibrinogen and the oxidative stress in the localization of atherosclerotic lesions in the ASO patients .

  21. 目的:分析比较冠心病(CHD)及健康者男女β纤维蛋白原基因启动子区Hae(βHae)多态性和血浆纤维蛋白原浓度的差异。

    To compare the difference of β fibrinogen gene Hae ⅲ polymorphisms and plasma fibrinogen levels between men and women with coronary heart disease ( CHD ) and normal individuals .

  22. 评定指标包括脑卒中的临床神经功能缺损程度评分、Barthel指数、血浆纤维蛋白原水平、副作用。

    The evaluated indexes included clinical neurological defect scale of stroke , Barthel Index , the level of plasma fibrinogen ( FIB ) and side effects .

  23. 结论男性人群血浆纤维蛋白原水平受β纤维蛋白原基因启动子区455A/G多态性的影响,H2等位基因可能?

    Conclusion Plasma fibrinogen expression is affected by the β - fibrinogen gene - 455A / G polymorphism , and the H2 allele may be a risk factor for ischemic stroke in Chinese males .

  24. 纤维蛋白原活性和抗原分别用Clauss法和免疫比浊法检测,westernblot分析血浆纤维蛋白原及其片断分布。

    The activity and antigen of fibrinogen in plasma were determined by Clauss and immunoturbidimetry , respectively . Fibrinogen and its constituents were analyzed in western blot with nonreducing 4 % 20 % SDS-PAGE .

  25. 目的动态监测巴曲酶治疗急性脑梗死患者血浆纤维蛋白原(Fib)水平变化,以探讨降纤治疗的靶水平。

    Objective To explore the dynamical change of fibrinogen levels treated by Batroxobin in patients with acute cerebral infarction in order to approach a target level of defibrinogen therapy .

  26. 目的观察2型糖尿病患者颈动脉内膜中层厚度(IMT)和血浆纤维蛋白原(Fg)的变化,并探讨其相关性。

    Objective To investigate the relationship between carotid intima media thickness ( IMT ) and plasma fibrinogen ( Fg ) in patients with type 2 diabetes mellitus ( T 2DM ) .

  27. 治疗组用药后血浆纤维蛋白原(FIB)水平比对照组显著下降(P<0.01),治疗组无增加出血事件及其他副作用。

    The level of plasma FIB in treatment group was remarkably declined after treatment ( P < 0.01 ) whereas the bleeding event and other side effect did not increase .

  28. 急性脑梗死的OCSP分型与头MRI、血管病变的相关性研究及预后分析2.血浆纤维蛋白原水平和基因多态性与脑血管病的相关性研究

    Relationship between Oxfordshire Community Stroke Project Clinical Classification , Brain MRI and Pattern of Artery Abnormalities in Acute Cerebral Infarction 2 . Association of Fibrinogen Level , Gene Polymorphisms and Cerebral Infarction

  29. 本研究对冠心病患者应用噻氯吡啶对血小板聚集功能(Plateletaggregation,PAg)及血浆纤维蛋白原(fibrinogen,Fg)水平的影响进行探讨并与乙酰水杨酸(acetylsalicyliaacid,ASA)进行比较。

    The effects of ticlopidine on platelet aggregation ( PAg ) and plasma fibrinogen ( Fg ) level were investigated and compared with those of acetylsalicylic acid ( ASA ) in patients with coronary artery disease ( CAD ) .

  30. 结论β-纤维蛋白原基因启动子区HaeⅢ-455G/A多态性虽可影响血浆纤维蛋白原浓度,但并非是缺血性脑血管病的一个重要遗传决定因子。

    Conclusion Although a minor effect on plasma fibrinogen cannot be excluded , - 455G / A polymorphism of the β - fibrinogen gene does not appear to be an important genetic determinant of ICVD .